ARBUTUS BIOPHARMA CORP (ABUS): Ownership & Insider Activity

Hedge funds and institutional managers reporting a position in ABUS · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
11
13F filers
Aggregate Value
$22.9M
Across holders
Last Price
$5.20
2026-08-24
Sector
Health Care
GICS
Quarterly fund activity7 increased3 reduced4 exited
Full exits: BALYASNY ASSET MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, Gotham Asset Management, LLC
Institutional Holders of ABUS
11 holders
ManagerTypeSharesMarket Value% of Total% of PortfolioActionQoQ ChangeQuarter
Woodline Partners LP
CIK 0001784547
Hedge Fund2.28M$11.0M47.8%0.0%Added+$1.3MQ2 2026
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
CIK 0001164508
Hedge Fund651K$3.1M13.6%0.0%AddedQ2 2026
Man Group plc
CIK 0001637460
Hedge Fund473K$2.3M9.9%0.0%AddedQ2 2026
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund405K$1.9M8.5%0.0%Reduced+$1.8MQ2 2026
SHAW D E & CO INC
CIK 0001009207
Hedge Fund382K$1.8M8.0%0.0%Added+$1.3MQ2 2026
Squarepoint Ops LLC
CIK 0001642575
Hedge Fund208K$999K4.4%0.0%AddedQ2 2026
Hudson Bay Capital Management LP
CIK 0001393825
Hedge Fund150K$720K3.1%0.0%Reduced$-960KQ2 2026
TWO SIGMA INVESTMENTS, LP
CIK 0001179392
Hedge Fund85K$408K1.8%0.0%AddedQ2 2026
Rockefeller Capital Management L.P.
CIK 0001739439
Hedge Fund63K$302K1.3%0.0%Unchanged+$0Q2 2026
Magnetar Financial LLC
CIK 0001352851
Hedge Fund47K$226K1.0%0.0%Reduced$-55KQ2 2026
110 of 11
1 / 2
Loading recent insider activity…